 | • レポートコード：QYR2104Z0941 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、骨肉腫のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法）、用途別市場規模（原発性骨がん、続発性骨がん）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・骨肉腫の市場動向 ・企業の競争状況、市場シェア ・骨肉腫の種類別市場規模（化学療法、標的療法） ・骨肉腫の用途別市場規模（原発性骨がん、続発性骨がん） ・骨肉腫の北米市場規模2016-2027（アメリカ、カナダ） ・骨肉腫のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・骨肉腫のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・骨肉腫の中南米市場規模2016-2027（メキシコ、ブラジル） ・骨肉腫の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Baxter、Bayer、Hikma Pharmaceuticals、Johnson＆Johnson、Recordati Group、Novartis AG、Pfizer、Takeda Pharmaceutical） ・結論 |
Bone cancer can begin in any bone in the body, but it most commonly affects the pelvis or the long bones in the arms and legs. Bone cancer is rare, making up less than 1 percent of all cancers. In fact, noncancerous bone tumors are much more common than cancerous ones.
Market Analysis and Insights: Global Bone Cancer Market
The global Bone Cancer market size is projected to reach US$ 72740 million by 2026, from US$ 55130 million in 2019, at a CAGR of 4.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bone Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bone Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bone Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bone Cancer market.
Global Bone Cancer Scope and Market Size
Bone Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bone Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Targeted Therapy
Segment by Application
Primary Bone Cancer
Secondary Bone Cancer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
Baxter
Bayer
Hikma Pharmaceuticals
Johnson＆Johnson
Recordati Group
Novartis AG
Pfizer
Takeda Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bone Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.3 Market by Application
1.3.1 Global Bone Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Primary Bone Cancer
1.3.3 Secondary Bone Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bone Cancer Market Perspective (2016-2027)
2.2 Bone Cancer Growth Trends by Regions
2.2.1 Bone Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bone Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Bone Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Bone Cancer Industry Dynamic
2.3.1 Bone Cancer Market Trends
2.3.2 Bone Cancer Market Drivers
2.3.3 Bone Cancer Market Challenges
2.3.4 Bone Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bone Cancer Players by Revenue
3.1.1 Global Top Bone Cancer Players by Revenue (2016-2021)
3.1.2 Global Bone Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Bone Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bone Cancer Revenue
3.4 Global Bone Cancer Market Concentration Ratio
3.4.1 Global Bone Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bone Cancer Revenue in 2020
3.5 Bone Cancer Key Players Head office and Area Served
3.6 Key Players Bone Cancer Product Solution and Service
3.7 Date of Enter into Bone Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bone Cancer Breakdown Data by Type
4.1 Global Bone Cancer Historic Market Size by Type (2016-2021)
4.2 Global Bone Cancer Forecasted Market Size by Type (2022-2027)
5 Bone Cancer Breakdown Data by Application
5.1 Global Bone Cancer Historic Market Size by Application (2016-2021)
5.2 Global Bone Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bone Cancer Market Size (2016-2027)
6.2 North America Bone Cancer Market Size by Type
6.2.1 North America Bone Cancer Market Size by Type (2016-2021)
6.2.2 North America Bone Cancer Market Size by Type (2022-2027)
6.2.3 North America Bone Cancer Market Size by Type (2016-2027)
6.3 North America Bone Cancer Market Size by Application
6.3.1 North America Bone Cancer Market Size by Application (2016-2021)
6.3.2 North America Bone Cancer Market Size by Application (2022-2027)
6.3.3 North America Bone Cancer Market Size by Application (2016-2027)
6.4 North America Bone Cancer Market Size by Country
6.4.1 North America Bone Cancer Market Size by Country (2016-2021)
6.4.2 North America Bone Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Bone Cancer Market Size (2016-2027)
7.2 Europe Bone Cancer Market Size by Type
7.2.1 Europe Bone Cancer Market Size by Type (2016-2021)
7.2.2 Europe Bone Cancer Market Size by Type (2022-2027)
7.2.3 Europe Bone Cancer Market Size by Type (2016-2027)
7.3 Europe Bone Cancer Market Size by Application
7.3.1 Europe Bone Cancer Market Size by Application (2016-2021)
7.3.2 Europe Bone Cancer Market Size by Application (2022-2027)
7.3.3 Europe Bone Cancer Market Size by Application (2016-2027)
7.4 Europe Bone Cancer Market Size by Country
7.4.1 Europe Bone Cancer Market Size by Country (2016-2021)
7.4.2 Europe Bone Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bone Cancer Market Size (2016-2027)
8.2 Asia-Pacific Bone Cancer Market Size by Type
8.2.1 Asia-Pacific Bone Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bone Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bone Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Bone Cancer Market Size by Application
8.3.1 Asia-Pacific Bone Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bone Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bone Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Bone Cancer Market Size by Region
8.4.1 Asia-Pacific Bone Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bone Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bone Cancer Market Size (2016-2027)
9.2 Latin America Bone Cancer Market Size by Type
9.2.1 Latin America Bone Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Bone Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Bone Cancer Market Size by Type (2016-2027)
9.3 Latin America Bone Cancer Market Size by Application
9.3.1 Latin America Bone Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Bone Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Bone Cancer Market Size by Application (2016-2027)
9.4 Latin America Bone Cancer Market Size by Country
9.4.1 Latin America Bone Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Bone Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bone Cancer Market Size (2016-2027)
10.2 Middle East & Africa Bone Cancer Market Size by Type
10.2.1 Middle East & Africa Bone Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bone Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bone Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Bone Cancer Market Size by Application
10.3.1 Middle East & Africa Bone Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bone Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bone Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Bone Cancer Market Size by Country
10.4.1 Middle East & Africa Bone Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bone Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Bone Cancer Introduction
11.1.4 Amgen Revenue in Bone Cancer Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Baxter
11.2.1 Baxter Company Details
11.2.2 Baxter Business Overview
11.2.3 Baxter Bone Cancer Introduction
11.2.4 Baxter Revenue in Bone Cancer Business (2016-2021)
11.2.5 Baxter Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Bone Cancer Introduction
11.3.4 Bayer Revenue in Bone Cancer Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Hikma Pharmaceuticals
11.4.1 Hikma Pharmaceuticals Company Details
11.4.2 Hikma Pharmaceuticals Business Overview
11.4.3 Hikma Pharmaceuticals Bone Cancer Introduction
11.4.4 Hikma Pharmaceuticals Revenue in Bone Cancer Business (2016-2021)
11.4.5 Hikma Pharmaceuticals Recent Development
11.5 Johnson＆Johnson
11.5.1 Johnson＆Johnson Company Details
11.5.2 Johnson＆Johnson Business Overview
11.5.3 Johnson＆Johnson Bone Cancer Introduction
11.5.4 Johnson＆Johnson Revenue in Bone Cancer Business (2016-2021)
11.5.5 Johnson＆Johnson Recent Development
11.6 Recordati Group
11.6.1 Recordati Group Company Details
11.6.2 Recordati Group Business Overview
11.6.3 Recordati Group Bone Cancer Introduction
11.6.4 Recordati Group Revenue in Bone Cancer Business (2016-2021)
11.6.5 Recordati Group Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Bone Cancer Introduction
11.7.4 Novartis AG Revenue in Bone Cancer Business (2016-2021)
11.7.5 Novartis AG Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Bone Cancer Introduction
11.8.4 Pfizer Revenue in Bone Cancer Business (2016-2021)
11.8.5 Pfizer Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Details
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Bone Cancer Introduction
11.9.4 Takeda Pharmaceutical Revenue in Bone Cancer Business (2016-2021)
11.9.5 Takeda Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bone Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Global Bone Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Bone Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bone Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Bone Cancer Market Share by Regions (2016-2021)
Table 8. Global Bone Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Bone Cancer Market Share by Regions (2022-2027)
Table 10. Bone Cancer Market Trends
Table 11. Bone Cancer Market Drivers
Table 12. Bone Cancer Market Challenges
Table 13. Bone Cancer Market Restraints
Table 14. Global Bone Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Bone Cancer Market Share by Players (2016-2021)
Table 16. Global Top Bone Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Cancer as of 2020)
Table 17. Ranking of Global Top Bone Cancer Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Bone Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bone Cancer Product Solution and Service
Table 21. Date of Enter into Bone Cancer Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bone Cancer Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Bone Cancer Revenue Market Share by Type (2016-2021)
Table 25. Global Bone Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Bone Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Bone Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Bone Cancer Revenue Market Share by Application (2016-2021)
Table 29. Global Bone Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Bone Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Bone Cancer Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Bone Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Bone Cancer Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Bone Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Bone Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Bone Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Bone Cancer Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Bone Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Bone Cancer Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Bone Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Bone Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Bone Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Bone Cancer Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Bone Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bone Cancer Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bone Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bone Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Bone Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Bone Cancer Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Bone Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Bone Cancer Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Bone Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Bone Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Bone Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Bone Cancer Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Bone Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bone Cancer Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bone Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bone Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Bone Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 61. Amgen Company Details
Table 62. Amgen Business Overview
Table 63. Amgen Bone Cancer Product
Table 64. Amgen Revenue in Bone Cancer Business (2016-2021) & (US$ Million)
Table 65. Amgen Recent Development
Table 66. Baxter Company Details
Table 67. Baxter Business Overview
Table 68. Baxter Bone Cancer Product
Table 69. Baxter Revenue in Bone Cancer Business (2016-2021) & (US$ Million)
Table 70. Baxter Recent Development
Table 71. Bayer Company Details
Table 72. Bayer Business Overview
Table 73. Bayer Bone Cancer Product
Table 74. Bayer Revenue in Bone Cancer Business (2016-2021) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Hikma Pharmaceuticals Company Details
Table 77. Hikma Pharmaceuticals Business Overview
Table 78. Hikma Pharmaceuticals Bone Cancer Product
Table 79. Hikma Pharmaceuticals Revenue in Bone Cancer Business (2016-2021) & (US$ Million)
Table 80. Hikma Pharmaceuticals Recent Development
Table 81. Johnson＆Johnson Company Details
Table 82. Johnson＆Johnson Business Overview
Table 83. Johnson＆Johnson Bone Cancer Product
Table 84. Johnson＆Johnson Revenue in Bone Cancer Business (2016-2021) & (US$ Million)
Table 85. Johnson＆Johnson Recent Development
Table 86. Recordati Group Company Details
Table 87. Recordati Group Business Overview
Table 88. Recordati Group Bone Cancer Product
Table 89. Recordati Group Revenue in Bone Cancer Business (2016-2021) & (US$ Million)
Table 90. Recordati Group Recent Development
Table 91. Novartis AG Company Details
Table 92. Novartis AG Business Overview
Table 93. Novartis AG Bone Cancer Product
Table 94. Novartis AG Revenue in Bone Cancer Business (2016-2021) & (US$ Million)
Table 95. Novartis AG Recent Development
Table 96. Pfizer Company Details
Table 97. Pfizer Business Overview
Table 98. Pfizer Revenue in Bone Cancer Business (2016-2021) & (US$ Million)
Table 99. Pfizer Recent Development
Table 100. Takeda Pharmaceutical Company Details
Table 101. Takeda Pharmaceutical Business Overview
Table 102. Takeda Pharmaceutical Bone Cancer Product
Table 103. Takeda Pharmaceutical Revenue in Bone Cancer Business (2016-2021) & (US$ Million)
Table 104. Takeda Pharmaceutical Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bone Cancer Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Global Bone Cancer Market Share by Application: 2020 VS 2027
Figure 5. Primary Bone Cancer Case Studies
Figure 6. Secondary Bone Cancer Case Studies
Figure 7. Bone Cancer Report Years Considered
Figure 8. Global Bone Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Bone Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Bone Cancer Market Share by Regions: 2020 VS 2027
Figure 11. Global Bone Cancer Market Share by Regions (2022-2027)
Figure 12. Global Bone Cancer Market Share by Players in 2020
Figure 13. Global Top Bone Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Cancer as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Bone Cancer Revenue in 2020
Figure 15. Global Bone Cancer Revenue Market Share by Type (2016-2021)
Figure 16. Global Bone Cancer Revenue Market Share by Type (2022-2027)
Figure 17. North America Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Bone Cancer Market Share by Type (2016-2027)
Figure 19. North America Bone Cancer Market Share by Application (2016-2027)
Figure 20. North America Bone Cancer Market Share by Country (2016-2027)
Figure 21. United States Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Bone Cancer Market Share by Type (2016-2027)
Figure 25. Europe Bone Cancer Market Share by Application (2016-2027)
Figure 26. Europe Bone Cancer Market Share by Country (2016-2027)
Figure 27. Germany Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Bone Cancer Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Bone Cancer Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Bone Cancer Market Share by Region (2016-2027)
Figure 37. China Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Bone Cancer Market Share by Type (2016-2027)
Figure 45. Latin America Bone Cancer Market Share by Application (2016-2027)
Figure 46. Latin America Bone Cancer Market Share by Country (2016-2027)
Figure 47. Mexico Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Bone Cancer Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Bone Cancer Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Bone Cancer Market Share by Country (2016-2027)
Figure 53. Turkey Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Bone Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Amgen Revenue Growth Rate in Bone Cancer Business (2016-2021)
Figure 57. Baxter Revenue Growth Rate in Bone Cancer Business (2016-2021)
Figure 58. Bayer Revenue Growth Rate in Bone Cancer Business (2016-2021)
Figure 59. Hikma Pharmaceuticals Revenue Growth Rate in Bone Cancer Business (2016-2021)
Figure 60. Johnson＆Johnson Revenue Growth Rate in Bone Cancer Business (2016-2021)
Figure 61. Recordati Group Revenue Growth Rate in Bone Cancer Business (2016-2021)
Figure 62. Novartis AG Revenue Growth Rate in Bone Cancer Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Bone Cancer Business (2016-2021)
Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Bone Cancer Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の骨肉腫診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bone Cancer Diagnosis and Therapeutics Market The global Bone Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…- 世界の骨肉腫診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bone Cancer Diagnosis and Therapeutics Market The global Bone Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
- 世界の骨肉腫治療市場規模・現状・予測（2021年-2027年） There are diagnostic tests and treatment steps for bone cancer, starting with ultrasound, a CBC, biopsy, and other diagnostic tests.They were then treated with drugs such as corticosteroids, non-steroidal anti-inflammatory drugs and immunosuppressants and surgery.Corticosteroids include difluprednis…
- 世界の骨肉腫治療市場規模・現状・予測（2021年-2027年） There are diagnostic tests and treatment steps for bone cancer, starting with ultrasound, a CBC, biopsy, and other diagnostic tests.They were then treated with drugs such as corticosteroids, non-steroidal anti-inflammatory drugs and immunosuppressants and surgery.Corticosteroids include difluprednis…
- 世界の骨転移治療市場規模・現状・予測（2021年-2027年） Bone metastasis is the third most common condition in metastatic cancers and occurs in 60-65% of patients with metastatic cancers. The spine is the most common site of bone metastasis. Other common sites include ribs, skull, pelvis (hip bone), femur (leg bone) and humerus (arm bone). Bone metastatic…